Immunological and antibiofilm property of haemocyanin purified from grooved tiger shrimp (Penaeus semisulcatus): An in vitro and in silico approach

Ishwarya, Ramachandran; Iswarya, Arokiadas; Thangaviji, Vijayaragavan; Sivakamavalli, J.; Esteban, M. Ángeles; Thangaraj, Merlin P.; Vaseeharan, Baskaralingam

doi:10.1016/j.micpath.2020.104253

Cited by 8 publications

(2 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Plates were incubated for 18–22 h at 37 °C with 5% CO 2 then read spectrophotometrically at OD 600 to measure antimicrobial activity. The same plates were evaluated for inhibition of biofilm formation, similar to [ [29] , [30] , [31] ]. Planktonic bacteria and media were carefully aspirated from wells before 200 μL PBS was added to each well then discarded and repeated to rinse.…”

Section: Methodsmentioning

confidence: 99%

Out of control: The need for standardised solvent approaches and data reporting in antibiofilm assays incorporating dimethyl-sulfoxide (DMSO)

Summer

Browne

Hollanders

et al. 2022

Biofilm

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

Out of control: The need for standardised solvent approaches and data reporting in antibiofilm assays incorporating dimethyl-sulfoxide (DMSO)

Summer

Browne

Hollanders

et al. 2022

Biofilm

View full text Add to dashboard Cite

“…As well, Maselli et al [170] recently reported antibiofilm activity (60% eradication at 80 μM) among peptides derived from the suckers of O vulgaris. Preliminary evidence indicates that Hcs from marine crustaceans can also inhibit biofilm formation (at 0.1 mg/mL) [180][181][182] and molluscan Hcs could function similarly.…”

Section: Antimicrobial Activitymentioning

confidence: 99%

Molluscan Compounds Provide Drug Leads for the Treatment and Prevention of Respiratory Disease

et al. 2020

View full text Add to dashboard Cite

Respiratory diseases place an immense burden on global health and there is a compelling need for the discovery of new compounds for therapeutic development. Here, we identify research priorities by critically reviewing pre-clinical and clinical studies using extracts and compounds derived from molluscs, as well as traditional molluscan medicines, used in the treatment of respiratory diseases. We reviewed 97 biomedical articles demonstrating the anti-inflammatory, antimicrobial, anticancer, and immunomodulatory properties of >320 molluscan extracts/compounds with direct relevance to respiratory disease, in addition to others with promising bioactivities yet to be tested in the respiratory context. Of pertinent interest are compounds demonstrating biofilm inhibition/disruption and antiviral activity, as well as synergism with approved antimicrobial and chemotherapeutic agents. At least 100 traditional medicines, incorporating over 300 different mollusc species, have been used to treat respiratory-related illness in cultures worldwide for thousands of years. These medicines provide useful clues for the discovery of bioactive components that likely underpin their continued use. There is particular incentive for investigations into anti-inflammatory compounds, given the extensive application of molluscan traditional medicines for symptoms of inflammation, and shells, which are the principal molluscan product used in these preparations. Overall, there is a need to target research toward specific respiratory disease-related hypotheses, purify bioactive compounds and elucidate their chemical structures, and develop an evidence base for the integration of quality-controlled traditional medicines.

show abstract

Methanol Skin Mucus Extract of Mrigal (Cirrhinus mrigala) Fish Peptide Targeting Viral Particles of Infectious Pancreatic Necrosis Virus (IPNV) and Infectious Salmon Anemia Virus (ISAV): an in silico Approach

Sridhar

Manikandan

Marimuthu

et al. 2021

Int J Pept Res Ther

View full text Add to dashboard Cite

Immunological and antibiofilm property of haemocyanin purified from grooved tiger shrimp (Penaeus semisulcatus): An in vitro and in silico approach

Cited by 8 publications

References 44 publications

Out of control: The need for standardised solvent approaches and data reporting in antibiofilm assays incorporating dimethyl-sulfoxide (DMSO)

Out of control: The need for standardised solvent approaches and data reporting in antibiofilm assays incorporating dimethyl-sulfoxide (DMSO)

Molluscan Compounds Provide Drug Leads for the Treatment and Prevention of Respiratory Disease

Methanol Skin Mucus Extract of Mrigal (Cirrhinus mrigala) Fish Peptide Targeting Viral Particles of Infectious Pancreatic Necrosis Virus (IPNV) and Infectious Salmon Anemia Virus (ISAV): an in silico Approach

Contact Info

Product

Resources

About